An evidence-first reference for 56 research peptides and compounds. Each entry summarizes mechanism of action, published research findings, pharmacokinetics, handling, and reported safety signals. Educational only, for laboratory research use.
Incretin and metabolic research compounds studied for body-weight regulation, glucose handling, and adipose signaling.
A dual incretin receptor agonist studied for metabolic and glycemic outcomes.
5mg · 10mg · 15mg · 20mg · 30mg · 40mg · 50mg · 60mgAn investigational triple incretin agonist studied for weight and metabolic endpoints.
5mg · 10mg · 15mg · 20mg · 30mg · 40mg · 50mg · 60mgA long-acting GLP-1 receptor agonist studied for glycemic and weight outcomes.
2mg · 5mg · 10mg · 15mg · 20mg · 30mgAn investigational long-acting amylin analog studied for satiety and weight.
5mg · 10mgAn investigational GLP-1/glucagon dual agonist studied for weight and liver outcomes.
10mgA modified growth-hormone fragment studied for its effects on fat metabolism in research models.
2mg · 5mg · 10mgA small-molecule NNMT inhibitor studied for effects on cellular NAD metabolism and adipocyte energetics.
5mg · 50mgA targeted pro-apoptotic peptidomimetic studied for effects on white adipose tissue vasculature.
2mg · 5mgA mitochondrial-derived peptide studied for roles in metabolic regulation and cellular stress response.
10mg · 20mg · 30mg · 40mgA small-molecule AMPK activator studied for effects on cellular energy metabolism and endurance models.
50mgGH, GHRH analogs, and growth-hormone secretagogues studied for the somatotropic axis, recovery, and body composition.
A stabilized growth-hormone-releasing hormone analog studied for endogenous GH secretion and visceral fat.
2mg · 5mg · 10mg · 20mgRecombinant 191-amino-acid human growth hormone identical in sequence to the endogenous hormone.
10iu · 12iu · 15iu · 24iuA modified, long-acting IGF-1 analog studied for its prolonged anabolic signaling activity.
0.1mg · 1mgA selective pentapeptide growth hormone secretagogue studied for clean, targeted GH release.
5mg · 10mgA GHRH analog with a Drug Affinity Complex studied for substantially extended circulating duration.
2mg · 5mgA short-acting modified GRF(1-29) GHRH analog studied for pulsatile growth hormone stimulation.
2mg · 5mg · 10mgA synthetic growth hormone secretagogue peptide widely studied in pituitary research models.
5mg · 10mg · 15mgAn early growth hormone secretagogue hexapeptide studied for ghrelin-receptor activity and appetite signaling.
5mg · 10mgA potent synthetic hexapeptide secretagogue studied for growth hormone release and cardiac receptor activity.
2mg · 5mg · 10mgA growth hormone-releasing hormone analog studied as the active fragment of endogenous GHRH.
5mg · 10mgA splice variant of IGF-1 studied for its role in mechanically induced muscle tissue signaling.
2mgA PEGylated form of Mechano Growth Factor studied for extended stability over native MGF.
2mgA synthetic C-terminal growth hormone fragment studied for fat-metabolism signaling in research models.
5mgCytoprotective and tissue-repair research peptides studied for soft-tissue, gut, and connective-tissue models.
A synthetic pentadecapeptide studied in preclinical models of tissue repair and gut protection.
5mg · 10mgA synthetic peptide related to thymosin beta-4, studied in preclinical tissue-repair and cell-migration research.
2mg · 5mg · 10mgA naturally occurring copper-binding tripeptide studied for roles in skin remodeling and gene expression.
50mg · 100mgA tripeptide fragment of alpha-MSH studied for anti-inflammatory signaling in preclinical models.
10mgA human cathelicidin-derived peptide studied for antimicrobial and immunomodulatory properties.
5mgAn endogenous neuropeptide studied for roles in vasodilation, immune regulation, and signaling.
10mgAn erythropoietin-derived peptide studied for tissue protection without effects on red blood cells.
10mgA naturally occurring amphibian opioid heptapeptide studied for potent receptor activity in research.
5mgResearch compounds studied for telomere biology, mitochondrial function, senescence, and cellular aging.
Synthetic pineal tetrapeptide studied in animal models for telomerase activity and lifespan endpoints
10mg · 50mgCentral redox coenzyme studied for roles in metabolism, DNA repair, and cellular aging
100mg · 500mg · 1000mgMitochondria-targeted tetrapeptide studied for cardiolipin binding and bioenergetic preservation
10mg · 50mgEngineered D-retro-inverso peptide studied as a senolytic disrupting FOXO4-p53 interaction
10mgThymus-derived polypeptide fraction studied for immune modulation and age-related endpoints
10mgNootropic and neuromodulatory research peptides studied for cognition, anxiety models, and sleep architecture.
Synthetic tuftsin-analog heptapeptide studied for anxiolytic and neuromodulatory effects
5mg · 10mgSynthetic ACTH(4-10) analog studied for neuroprotective and cognitive-enhancing effects
5mg · 10mgEndogenous nonapeptide studied for associations with sleep regulation and stress response
5mg · 10mgPineal hormone central to circadian rhythm regulation and studied for sleep and aging
10mgEndogenous nonapeptide hormone studied for roles in social behavior, bonding, and physiology
2mg · 5mg · 10mgThymic and immunomodulatory peptides studied for immune signaling and regulation.
Melanocortin-system research peptides studied for libido models and melanogenesis.
A melanocortin receptor agonist peptide studied for its centrally mediated effects on sexual response.
10mgA synthetic cyclic melanocortin agonist studied for pigmentation and sexual-response effects.
10mgA linear melanocortin analog studied chiefly for MC1R-driven photoprotective pigmentation effects.
10mgA decapeptide fragment of kisspeptin studied as an upstream regulator of reproductive hormone signaling.
5mg · 10mgGonadotropin and reproductive-axis research compounds studied in endocrine models.
A placental glycoprotein hormone studied for its LH-like stimulation of gonadal steroidogenesis.
5000iu · 10000iuA purified gonadotropin preparation studied for its combined FSH-like and LH-like reproductive activity.
75iuA synthetic form of GnRH studied for its pulsatile stimulation of pituitary gonadotropin release.
2mgResearch peptides studied for dermal, collagen, and aesthetic endpoints.
Pre-combined research blends pairing complementary peptides in a single vial.
A research blend pairing an amylin analog with a GLP-1 receptor agonist studied for metabolic effects.
5mg+5mgA research blend pairing a gastric pentadecapeptide with a thymosin fragment for recovery studies.
5mg+5mg · 10mg+10mgA research blend pairing a GHRH analog with a selective ghrelin-mimetic growth hormone secretagogue.
5mg+5mgA three-component research blend adding a copper-binding peptide to the recovery pairing for repair studies.
10mg+10mg+50mgA four-component research blend adding an alpha-MSH fragment for anti-inflammatory repair studies.
10mg+10mg+50mg+10mgReconstitution and handling supplies for laboratory research workflows.